Page last updated: 2024-11-05

tofisopam and Irritable Bowel Syndrome

tofisopam has been researched along with Irritable Bowel Syndrome in 2 studies

tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effects of dextofisopam in men and women with diarrhoea-predominant or alternating irritable bowel syndrome (IBS) (d-IBS or a-IBS)."9.13Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome. ( Frissora, CL; Kassem, N; Keogh, JC; Leventer, SM; Mangel, AW; Phillips, J; Raudibaugh, K, 2008)
"To evaluate the effects of dextofisopam in men and women with diarrhoea-predominant or alternating irritable bowel syndrome (IBS) (d-IBS or a-IBS)."5.13Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome. ( Frissora, CL; Kassem, N; Keogh, JC; Leventer, SM; Mangel, AW; Phillips, J; Raudibaugh, K, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manabe, N1
Rao, AS1
Wong, BS1
Camilleri, M1
Leventer, SM1
Raudibaugh, K1
Frissora, CL1
Kassem, N1
Keogh, JC1
Phillips, J1
Mangel, AW1

Reviews

1 review available for tofisopam and Irritable Bowel Syndrome

ArticleYear
Emerging pharmacologic therapies for irritable bowel syndrome.
    Current gastroenterology reports, 2010, Volume: 12, Issue:5

    Topics: Alprostadil; Analgesics; Anti-Inflammatory Agents; Benzodiazepines; Bile Acids and Salts; Chloride C

2010

Trials

1 trial available for tofisopam and Irritable Bowel Syndrome

ArticleYear
Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Alimentary pharmacology & therapeutics, 2008, Jan-15, Volume: 27, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Antidiarrheals; Benzodiazepines; Diarrhea; Double-Blind Method; Female;

2008